NCT03456947View on ClinicalTrials.gov

Pregabalin Stabilize Cardiovascular Response to Intubation

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Effect of Laryngoscopy and Tracheal Intubation
Interventions
DRUG

Pregabalin

the patients receive 150mg or 300mg pregabalin 60 minutes prior to the surgery

All Listed Sponsors
lead

Shanghai Zhongshan Hospital

OTHER

NCT03456947 - Pregabalin Stabilize Cardiovascular Response to Intubation | Biotech Hunter | Biotech Hunter